论文信息 - Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. - 字舞流文

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

W. Scheithauer | L. Saltz | A. Figer | M. Lichinitser | J. Cassidy | F. Rivera | E. Díaz-Rubio | F. Couture | S. Koski | R. Wong | T.S. Yang | S. Clarke | F. Sirzén